MHC class I-Dependent and -Independent NK cell specificity

Chemical Immunology

Volumn 64, Issue , 1996, Pages 1-18

  Yokoyama, Wayne M ^a   Reichlin, Amy ^b   Margulies, David H ^b   Smith, Hamish R C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW; TARGET CELL;

ANIMALS; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL;

EID: 0029823254     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. Herberman RB: NK Cells and Other Natural Effector Cells. New York, Academic Press, 1982.
2. Reynolds CW, Wiltrout RH. Functions of the Natural Immune System. New York, Plenum Press, 1989.
3. Trinchieri G: Biology of natural killer cells. Adv Immunol 1989;47:187.
4. Kärre K, Ljunggren H-G, Piontek G, Kiessling R: Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defense strategy. Nature 1986;319-675
5. Piontek GE, Taniguchi K, Ljunggren H-G, Gronberg A, Kiessling R, Klein G, Karre K: YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after Interferon treatment or in vivo passage. J Immunol 1985;135:4281.
6. Quillet A, Presse F, Marchiol-Fournigault C, Harel-Bellan A, Benhunan M, Ploegh H, Fradelizi D: Increased resistance to non-MHC-restricted cytotoxicity related to HLA A, B expression Direct demonstration using beta-2-microglobulin-transfected Daudi cells. J Immunol 1988;141:17
7. Storkus WJ, Alexander J, Payne JA, Dawson JR, Cresswell P: Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. Proc Natl Acad Sci USA 1989;86:2361.
8. Liao N-S, Bix M, Zijistra M, Jaenisch R, Raulet D: MHC class I deficiency: Susceptibility to natural killer (NK) cells and impaired NK activity. Science 1991;253:199.
9. - bone marrow m chimeric mice. Proc Natl Acad Sci USA 1991;88:10332.
10. Kärre K: Role of target histocompatibility antigens in regulation of natural killer activity: A reevaluation and a hypothesis, in Herberman RB, Callewaert DM (eds): Mechanisms of Cytotoxicity by NK Cells. Orlando, Academic Press, 1985, pp 1-81.
11. Ljunggren H-G, Kärre K: In search of the 'missing self': MHC molecules and NK cell recognition Immunol today 1990;11:237.
12. Yokoyama WM: Recognition structures on natural killer cells Curr Opin Immunol 1993;5:67-73.
13. Wong S, Freeman JD, Kelleher C, Mager D, Takei F: Ly-49 multigene family. New members of a superfamily of type II membrane proteins with lectin-like domains. J Immunol 1991;147:1417.
14. Smith HRC, Karlhofer FM, Yokoyama WM: The Ly-49 multigene family expressed by IL-2-activated natural killer cells. J Immunol 1994;153:1068-1079.
15. Chan P-Y, Takei F: Molecular cloning and characterization of a novel murine T cell surface antigen, YE1/48. J Immunol 1989;142:1727.
16. Yokoyama WM, Jacobs LB, Kanagawa O, Shevach EM, Cohen DI: A murine T lymphocyte antigen belongs to a supergene family of type II integral membrane proteins. J Immunol 1989;143:1379.
17. Drickamer K: Two distinct classes of carbohydrate-recognition domains in animal lectins. J Biol Chem 1988;262:9557.
18. Chan P-Y, Takei F: Expression of a T-cell receptor-like molecule on normal and malignant murine T cells detected by rat monoclonal antibodies to nonclonotypic determinants. J Immunol 1986;136:1346.
19. Nagasawa R, Gross J, Kanagawa O, Townsend K, Lanier LL, Chiller J, Allison JP: Identification of a novel T cell surface disulfide-bonded dimer distinct from the α/β antigen receptor. J Immunol 1987;138:815.
20. Yokoyama WM, Kehn PJ, Cohen DI, Shevach EM: Chromosomal location of the Ly-49 (A1, YTE1/ 48) multigene family. Genetic association with the NK1. 1 antigen. J Immunol 1990;145:2353.
21. + IL-2-activated natural killer cells Nature 1992;358:66.
22. d globally inactivates NK cell cytolytic activity. Trans Assoc Am Physicians 1992;105:72.
23. Correa I, Corral L, Raulet DH: Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells. Eur Immunol 1994;24:1323-1331.
24. Karlhofer FM, Hunziker R, Reichlin A, Margulies DH, Yokoyama WM: Host MHC class I molecules modulate in vivo expression of a natural killer cell receptor J Immunol 1994;153:2407-2416.
25. Sykes M, Harty MW, Karlhofer FM, Pearson DA, Szot G, Yokoyama WM: Hematopoietic cells and radioresistant host elements influence natural killer cell differentiation. J Exp Med 1993;178: 223-229
26. Daniels BF, Karlhofer FM, Seaman WE, Yokoyama WM: A natural killer cell receptor specific for a major histocompatibility complex class I molecule. J Exp Med 1994;180:687-692
27. Kane KP: Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules J Exp Med 1994;179:1011.
28. Sun YH, Goodenow RS, Hood L: Molecular basis of the dm1 mutation in the major histocompatibility complex of the mouse: A D/L hybrid gene. J Exp Med 1985;162:1588.
29. Bjorkman PJ, Parham P: Structure, function and diversity of class I major histocompatibility molecules, Annu Rev Biochem 1990;59:253.
30. Jorgensen JL, Reay PA, Ehrici EW, Davis MM: Molecular components of T-cell recognition. Annu Rev Immunol 1992;10:835.
31. Salter RD, Norment AM, Chen BP, Clayberger C, Krensky AM, Littman DR, Parham P: Polymorphism in the α3 domain of HLA-A molecules affects binding to CD8. Nature 1989;338:345.
32. Potter TA, Rajan TV, Dick RF II, Bluestone JA: Substitution at residue 227 of H-2 class I molecules abrogates recognition by CD8-dependent, but not CD8-independent, cytotoxic T lymphocytes. Nature 1989;337:73.
33. Storkus WJ, Alexander J, Payne JA, Cresswell P, Dawson JR: The α1/α2 domains of class I HLA molecules confer resistance to natural killing. J Immunul 1989;143-3853.
34. Storkas WJ, Salter RD, Alexander J, Ward FE, Ruiz RE, Cresswell P, Dawson JR: Class I-induced resistance to natural killing: Identification of nonpermissive residues in HLA-A2. Proc Natl Acad Sci USA 1991;88:5989.
35. Chadwick BS, Miller RG: Hybrid resistance in vitro. Possible role of both class I MHC and self peptides in determining the level of target cell sensitivity. J Immunol 1992;2307-2313.
36. Chadwick BS, Sambhara SR, Sasakura Y, Miller RG: Effect of class I MHC binding peptides on recognition by natural killer cells. J Immunol 1992;149:3150-3156.
37. Storkus WJ, Salter RD, Cresswell P, Dawson JR: Peptide-induced modulation of target cell sensitivity to natural killing. J Immunol 1992;149:1185-1190
38. d, has a functional carbohydrate recognition domain. Immunity 1994;1:785-792.
39. Pullen JK, Horton RM, Cai Z, Pease LR: Structural diversity of the classical H-2 genes: K, D, and L. J Immunol 1992;148:953-967.
40. Hakomori S-I: Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 1989;52:257-331.
41. Springer TA, Lasky LA: Sticky sugars for selectins. Nature 1991;349:196-197.
42. Ishioka GY, Lamont AG, Thomson D, Bulbow N, Gaeta GC, Sette A, Grey HM: MHC interaction and T cell recognition of carbohydrates and glycopeptides. J Immunol 1992;148.2446-2451.
43. Hardmg CV, Kihlberg J, Elofsson M, Magnusson G, Unanue ER. Glycopeptides bind MHC molecules and elicit specific T cell responses. J Immunol 1993;151:2419-2425.
44. Vercelli D, Hlem B, Marsh P, Padlan E, Geha RS, Gould H: The B-cell binding site on human immunoglobulin E. Nature 1989;238:649-651.
45. Correa I, Rauler DH: Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity 1995;2:61-71.
46. Brennan J, Mager D, Jefferies W, Takei F: Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties J Exp Med 1994;180: 2287-2295.
47. Kubo S, Itoh Y, Ishikawa M, Nagasawa R, Mitarai T, Maruyama N: The gene encoding mouse lymphocyte antigen Ly-49. Structural analysis and the 5′-flanking sequence. Gene 1993;136:329-331.
48. Held W, Roland J, Raulet DH: Allelic exclusion of Ly49-family genes encoding class I MHC-specific receptors on NK cells. Nature 1995;376:355-358.
49. Hansen TH, Carreno BM, Sachs DH: The major histocompatibility complex; in Paul WE (ed): Fundamental Immunology New York, Raven Press 1993, pp 1-577.
50. Yu YYL, Kumar V, Bennett M. Murine natural killer cells and marrow graft rejection. Annu Rev Immunol 1992;10:189-213.
51. Rembecki RM, Kumar V, David CS, Bennett M: Bone marrow cell transplants involving intra-H-2 recombinant inbred mouse strains. Evidence that hemopoietic histocompatibility-1 genes are distinct from H-2D or H-2L. J Immunol 1988;141:2253.
52. Öhlén C, Kling G, Hoglund P, Hansson M, Scangos G, Bieberich C, Jay G, Karre K: Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science 1989;246: 666.
53. b bone marrow grafts. J Exp Med 1989;170:191.
54. Stoneman ER, Bennett M, An J, Chesnut KA, Wakeland EK, Scheerer JB, Siciliano MJ, Kumar V, Mathew PA: Cloning and characterization of 5E6 (Ly-49C), a receptor molecule expressed on a subset of murine natural killer cells J Exp Med 1995;182:305-313.
55. Brennan J, Takei F, Wong S, Mager DL. Carbohydrate recognition by a natural killer cell receptor, Ly-49C J Biol Chem 1995;270:9691-9694.
56. Yokoyama WM: Commentary. Hybrid resistance and the Ly-49 family of natural killer cell receptors J Exp Med 1995;182:273-277
57. Bellone G, Valiante NM, Viale O, Ciccone E, Moretta L, Trinchieri G: Regulation of hematopoiesis in vitro by alloreactive natural killer cell clones. J Exp Med 1993;177-117.
58. Perussia B. Lymphokine-activated killer cells, natural killer cells and cytokines Curr Opin Immunol 1991;3:49.
59. Mason L, Giardina SL, Hecht T, Ortaldo J, Mathieson BJ: LGL-1 A non-polymorphic antigen expressed on a major population of mouse natural killer cells J Immunol 1988;140:4403-4412.
60. Mason LH, Yagita H, Ortaldo JR: LGL-1: A potential triggering molecule on murine NK cells, J Leukol Biol 1994;55:362-370.
61. Mason LH, Ortaldo JR, Young HA, Kumar V, Bennett M, Anderson SK: Cloning and functional characteristics of murine large granular lymphocyte-1; A member of the Ly-49 gene family (Ly-49G2). J Exp Med 1995;182:293-303.
62. + cells generate lymphokine-activated killer cells J Immunol 1990;145:751-759
63. Moretta A, Vitale M, Bottino C, Orengo AM, Morelli L, Augugliaro R, Barbaresi M, Ciccone E, Moretta L: P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 1993;178:597-604.
64. Cella M, Longo A, Ferrara GB, Strominger JL, Colonna M: NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 1994;180:1235-1242.
65. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P: The Bw4 public epitope of HLA-B nolecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 1995;181:133-1144.
66. Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995;268:405-408.
67. Wagtmann N, Biassoni R, Cantoni C, Verdiam S, Malnati MS, Vitale M, Bottino C, Moretta L, Moretta A, Long EO: Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995;2:439-449.
68. D'Andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL: Molecular cloning of ZNKB1. A natural killer cell receptor for HLA-B allotypes. J Immunol 1995;155:2306-2310.
69. Gumperz JE, Parham P: The enigma of the natural killer cell. Nature 1995;378:245-248.
70. Yokoyama WM: Right-side-up and up-side-down NK cell receptors Curr Biol 1995;5:982-985.
71. + T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody J Immunol 1991;147:714-721.
72. Moretta A, Vitale M, Sivori S, Bottino C, Morelli L, Augagliaro R, Barbaresi M, Pende D, Ciccone E, López-Botet M, Moretta L. Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med 1994; 180 545-555.
73. Chang CW, Rodriguez A, Carretero M, Lopezbotet M, Phillips JH, Lanier LL. Molecular characterization of human CD94 - a type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol 1995;25:2433-2437.
74. Yokoyama WM, Seaman WE: The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: The NK gene complex Annu Rev Immunol 1993;11:613-635.
75. Yabe T, McSherry C, Bach FH, Fisch P, Schall RP, Sondel PM, Houchins JP: A multigene family on human chromosome 12 encodes natural killer-cell lectins. Immunogenetics 1993;37:455-460.
76. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley AS: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 1992;356:215-221.
77. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tisty TD: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 1992;70:923-935.
78. Harvey M, Sands AT, Weiss RS, Hegi ME, Wiseman RW, Pantazis A, Giovanella BC, Tainsky MA, Bradley A, Donehower LA: In vitro growth of embryo fibroblasts isolated from p53-deficient mice. Oncogene 1993;8:2457-2467.
79. Karlhofer FM, Orihuela MM, Yokoyama WM: Ly-49-independent NK cell specificity revealed by NK cell clones derived from p53-deficient mice. J Exp Med 1995;181:1785-1795.
80. Yokoyama WM: Natural killer cells and the NK gene complex, in Herzenberg LA, Herzenberg LA (eds): Handbook of Experimental Immunology 1996, in press.
81. Karlhofer FM, Yokoyama WM: Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways J Immunol 1995;146:3662-3673.
82. Vivier E, Morin P, O'Brien C, Druker B, Schlossman SF, Anderson P. Tyrosine phosphorylation of the FcγRIII (CD16):ζ complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing. J Immunol 1991;146:206-210.
83. Chambers WH, VujanovicNL, DeLeo AB, Olszowy MW, Herberman RB, Hiserodt JC: Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J Exp Med 1989;169:1373-1389
84. Ryan JC, Niemi EC, Goldfien RD, Hiserodt JC, Seaman WE: NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium J Immunol 1991;147:3244-3250
85. Ryan JC, Tuck J, Niemi EC, Yokoyama WM, Seaman WE: Molecular cloning of the NK1.1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules J Immunol 1992;149: 1631-1635.
86. Grani-Wagner BA, Purohit A, Mathew PA, Bennettt M, Kumar V: A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J Immunol 1993;151:60-70.
87. Mathew PA, Garni-Wagner BA, Land K, Takshima A, Stoneman E, Bennett M, Kumar V: Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J Immunol 1993;151:5328-5337.
88. Giardina GL, Anderson SK, Sayers TJ, Chambers WH, Palumbo GA, Young HA, Ortaldo JR: Selective loss of NK cytotoxicity in antisense NK-TR1 rat LGL cell lines. Abrogation of antibody-independent tumor and virus-infected target cell killing. J Immunol 1995;154:80-87.